Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,243 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07179315RecruitingPhase 2
Immunotherapy Study for HPV-Positive Head and Neck Cancer
This trial compares two different immunotherapy approaches for people with HPV-positive oropharyngeal cancer who have completed initial treatment like surgery, radiation, or chemotherapy. The goal is to see which option works better to keep the cancer from coming back, and eligibility is determined by a special blood test that detects HPV DNA.
Chicago, IllinoisAges 18 years+ - NCT07707778Enrolling by invitationPhase 4
Tirzepatide for Weight and Aging in People with HIV
This trial tests whether a weight-loss medicine called tirzepatide can slow biological aging and improve metabolism in people with HIV who are already on effective treatment. It may help you reduce weight and possibly reverse some signs of aging.
TaipeiAges 18 years+ - NCT05965336Recruiting
Walking test study for nerve damage in diabetes feet
This study looks at how well people with diabetes-related nerve damage (diabetic peripheral neuropathy) can walk, using a treadmill and walking distance tests. It may help improve understanding of walking limits and how to measure change over time.
Pensacola, FloridaAges 45 years+ - NCT06507189Recruiting
How exercise affects older adults: a study
This study looks at how different older adults respond to exercise. It will help researchers understand why some people benefit more than others. You will be asked to do supervised exercise sessions and tests over about 6 months.
Pensacola, FloridaAges 60 years+ - NCT06880705Recruiting
Trans-Led Care Study for alcohol and drug support
This study is testing a program designed by and for transgender adults to help with alcohol or drug use problems. It looks at whether a supportive, community-based approach can improve health and well-being.
Chicago, IllinoisAges 18 years+ - NCT05799144RecruitingPhase 2
Pembrolizumab plus investigational HPV drugs for throat cancer
This Phase 2 trial studies pembrolizumab (an immune therapy) combined with investigational treatment(s) pBI-11 and TA-HPV for advanced or recurrent oropharyngeal cancer that is HPV-positive and has certain immune marker levels (PD-L1 CPS ≥ 1). It may help your immune system better attack cancer.
Birmingham, AlabamaAges 18 years+ - NCT06764316RecruitingPhase 1
Safety study of BAY 3547926 for advanced liver cancer
This trial tests a new drug called BAY 3547926 for people with advanced liver cancer that cannot be removed with surgery or has not responded to other treatments. The goal is to see if the drug is safe and how well it works.
Dothan, AlabamaAges 18 years+ - NCT02991248Recruiting
Balance training for people with spinal cord injury
This study looks at a treatment to improve how well you can balance and stay steady while moving if you have a spinal cord injury. It may help with side-to-side (lateral) balance and walking control.
Chicago, IllinoisAges 18–65 - NCT03005132Recruiting
Study for people with newly diagnosed brain cancer (GBM)
This trial looks at people with glioblastoma (GBM), a fast-growing brain tumor, to better understand it and how treatments might work. You may be able to join if you’re in a good general health range and have not had prior cancer chemotherapy.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT03017820RecruitingPhase 1
Vaccine plus immune drugs for relapsed blood cancers
This early-phase trial tests a personalized-style vaccine (called VSV-hIFNβ-NIS) given alone or with other cancer-fighting medicines, including drugs that help the immune system attack. It is designed for people with certain relapsed or hard-to-treat multiple myeloma, acute myeloid leukemia, or lymphomas, to see if the treatment can shrink tumors and improve outcomes.
Scottsdale, ArizonaAges 18 years+ - NCT03089554RecruitingPhase 2
Genetic tumor testing to guide targeted cancer treatments
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
Lexington, KentuckyAges 18 years+ - NCT03151473Recruiting
Study of adults with fatty liver and NASH over time
This is a long-term study that follows adults who are being managed for fatty liver (NAFL) or NASH to learn how these conditions change over time. It may help researchers better understand what to expect and how care decisions could be improved.
Hong KongAges 18 years+ - NCT03190538Recruiting
Study of fatty liver inflammation in Chinese children
This trial looks at nonalcoholic steatohepatitis (fatty liver with inflammation) in children. It is meant to test whether a new approach can help improve this liver problem without being caused by alcohol or other known liver diseases.
BeijingAges 1–18 - NCT03300830Recruiting
Testing tumors linked to viruses, HIV, and immune disorders
This study collects and analyzes tumor tissue to learn what drives certain cancers and growths linked to viruses, HIV, and immune system problems. Results may help researchers understand disease causes and point to better future treatments.
Bethesda, MarylandAges 18 years+ - NCT03307317Recruiting
Testing brain signaling in infants at early risk
This study looks at how the brain “mirrors” or responds to actions, with the goal of finding early signs of neurodevelopmental disorders. It includes healthy adults and infants, and infants who may be at risk, to compare brain patterns early on.
Bethesda, MarylandAges 9 months–65 years - NCT03335644Recruiting
Internet-based health study for people 15 and older
This study gathers health information through an online program. It may help researchers understand how diet and lifestyle affect health over time.
Bobigny, Seine Saint DenisAges 15 years+ - NCT03400345Recruiting
Follow-up for transplanted arm patients
This study follows people who received a transplanted arm (or both arms) to learn from their ongoing care. You may be asked for small tissue samples (biopsies) and to continue an immunotherapy plan to help protect the transplant.
Baltimore, MarylandAges 18–100 - NCT03403699Recruiting
Stem cell treatment for damaged eye blood vessels in diabetes
This study tests human iPSC–derived (lab-grown) cells aimed at repairing fragile, damaged blood vessels in diabetic retinopathy. It also involves eye exams and a small skin biopsy to support the research.
Birmingham, AlabamaAges 21–98 - NCT03407066Recruiting
Study of how people see, hear, think, and move
This study measures how the brain processes sight and other senses through tests done in a lab, online, or by off-site/genetic screening. It may help researchers understand normal perception and cognition, which can guide future treatments.
Bethesda, MarylandAges 13–65 - NCT03437005RecruitingPhase 1
Testing how common skin creams change gut microbes
This study looks at whether commonly used topical (skin) medications change your skin and gut microbial “ecosystem.” It’s an early (Phase 1) pilot study, mainly to see how these treatments affect samples over time.
Sacramento, CaliforniaAges 18 years+ - NCT03465592RecruitingPhase 1/Phase 2
Nivolumab after mismatched bone marrow transplant for sarcoma
This trial studies nivolumab (an immune treatment) in people with sarcoma who already had a partially mismatched bone marrow transplant. It may help the new immune system recognize and attack cancer, and researchers will also watch closely for side effects like GVHD (immune reaction after transplant) and autoimmune problems.
St. Petersburg, FloridaAges 1–40 - NCT03612726Recruiting
Study for people with unresectable liver cancer
This trial looks at overall survival (how long people live) in real-world patients with unresectable liver cancer. It may help researchers understand outcomes outside of tightly controlled studies.
BeijingAges 18 years+ - NCT03631420RecruitingPhase 1
Stem cell treatment to prevent lung disease in very premature babies
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
TainanAges 3 days–2 months - NCT03644732Recruiting
Study of brain activity during epilepsy testing using SEEG
This study maps how thinking and memory work by recording brain signals during a presurgical epilepsy workup. It may help doctors better understand drug-resistant focal epilepsy and improve how they plan treatment.
GrenobleAges 18–65
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,243 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.